161 related articles for article (PubMed ID: 35524316)
1. A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders.
Robison R; Lafrance A; Brendle M; Smith M; Moore C; Ahuja S; Richards S; Hawkins N; Strahan E
J Eat Disord; 2022 May; 10(1):65. PubMed ID: 35524316
[TBL] [Abstract][Full Text] [Related]
2. Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants.
Robison R; Brendle M; Moore C; Cross H; Helm L; Darling S; Thayer S; Thielking P; Shannon S
J Psychoactive Drugs; 2024; 56(1):23-32. PubMed ID: 36862829
[TBL] [Abstract][Full Text] [Related]
3. Reductions in anxiety and depression symptoms in a subset of outpatients with problematic substance use who received ketamine-assisted psychotherapy: a two-year retrospective chart review.
Whinkin E; Eparwa TRJ; Julseth MC; Schneider A; Aggarwal SK
Front Psychiatry; 2023; 14():1160442. PubMed ID: 37711421
[TBL] [Abstract][Full Text] [Related]
4. Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses.
Wolfson PE; Andries J; Ahlers D; Whippo M
Front Psychiatry; 2023; 14():1141988. PubMed ID: 37065886
[TBL] [Abstract][Full Text] [Related]
5. Implementation of transdiagnostic treatment for emotional disorders in residential eating disorder programs: A preliminary pre-post evaluation.
Thompson-Brenner H; Boswell JF; Espel-Huynh H; Brooks G; Lowe MR
Psychother Res; 2019 Nov; 29(8):1045-1061. PubMed ID: 29553881
[No Abstract] [Full Text] [Related]
6. Case report: Intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa.
Keeler JL; Treasure J; Himmerich H; Brendle M; Moore C; Robison R
Front Psychiatry; 2023; 14():1181447. PubMed ID: 37255674
[TBL] [Abstract][Full Text] [Related]
7. A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers With PTSD and Depression.
Dames S; Kryskow P; Watler C
Front Psychiatry; 2021; 12():803279. PubMed ID: 35095617
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review.
Tsang VWL; Tao B; Dames S; Walsh Z; Kryskow P
Ther Adv Psychopharmacol; 2023; 13():20451253231171512. PubMed ID: 37256163
[TBL] [Abstract][Full Text] [Related]
9. At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial.
Hull TD; Malgaroli M; Gazzaley A; Akiki TJ; Madan A; Vando L; Arden K; Swain J; Klotz M; Paleos C
J Affect Disord; 2022 Oct; 314():59-67. PubMed ID: 35809678
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders.
Glue P; Neehoff SM; Medlicott NJ; Gray A; Kibby G; McNaughton N
J Psychopharmacol; 2018 Jun; 32(6):663-667. PubMed ID: 29561204
[TBL] [Abstract][Full Text] [Related]
11. Case Report: Unexpected Remission From Extreme and Enduring Bulimia Nervosa With Repeated Ketamine Assisted Psychotherapy.
Ragnhildstveit A; Jackson LK; Cunningham S; Good L; Tanner Q; Roughan M; Henrie-Barrus P
Front Psychiatry; 2021; 12():764112. PubMed ID: 34867548
[No Abstract] [Full Text] [Related]
12. Active mechanisms of ketamine-assisted psychotherapy: A systematic review.
Joneborg I; Lee Y; Di Vincenzo JD; Ceban F; Meshkat S; Lui LMW; Fancy F; Rosenblat JD; McIntyre RS
J Affect Disord; 2022 Oct; 315():105-112. PubMed ID: 35905796
[TBL] [Abstract][Full Text] [Related]
13. Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy.
Dore J; Turnipseed B; Dwyer S; Turnipseed A; Andries J; Ascani G; Monnette C; Huidekoper A; Strauss N; Wolfson P
J Psychoactive Drugs; 2019; 51(2):189-198. PubMed ID: 30917760
[TBL] [Abstract][Full Text] [Related]
14. The Association of Malnutrition, illness duration, and pre-morbid weight status with anxiety and depression symptoms in adolescents and young adults with restrictive eating disorders: a cross-sectional study.
Lin JA; Jhe G; Vitagliano JA; Milliren CE; Spigel R; Woods ER; Forman SF; Richmond TK
J Eat Disord; 2021 May; 9(1):60. PubMed ID: 34001260
[TBL] [Abstract][Full Text] [Related]
15. A Pilot Study Comparing a Community of Practice Program with and without Concurrent Ketamine-Assisted Therapy.
Tsang VWL; Ragazan DC; Kryskow P; Walsh Z; Dames S
J Psychoactive Drugs; 2023 Sep; ():1-10. PubMed ID: 37655532
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study.
Glue P; Medlicott NJ; Neehoff S; Surman P; Lam F; Hung N; Hung CT
Ther Adv Psychopharmacol; 2020; 10():2045125320922474. PubMed ID: 32523677
[TBL] [Abstract][Full Text] [Related]
17. Post-traumatic stress disorder as a moderator of transdiagnostic, residential eating disorder treatment outcome trajectory.
Scharff A; Ortiz SN; Forrest LN; Smith AR; Boswell JF
J Clin Psychol; 2021 Apr; 77(4):986-1003. PubMed ID: 33449390
[TBL] [Abstract][Full Text] [Related]
18. Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders.
Glue P; Medlicott NJ; Harland S; Neehoff S; Anderson-Fahey B; Le Nedelec M; Gray A; McNaughton N
J Psychopharmacol; 2017 Oct; 31(10):1302-1305. PubMed ID: 28441895
[TBL] [Abstract][Full Text] [Related]
19. Ketamine-assisted psychotherapy treatment of chronic pain and comorbid depression: a pilot study of two approaches.
Batievsky D; Weiner M; Kaplan SB; Thase ME; Maglione DN; Vidot DC
Front Pain Res (Lausanne); 2023; 4():1127863. PubMed ID: 37273242
[TBL] [Abstract][Full Text] [Related]
20. Component analysis of a synchronous and asynchronous blended care CBT intervention for symptoms of depression and anxiety: Pragmatic retrospective study.
Lungu A; Wickham RE; Chen SY; Jun JJ; Leykin Y; Chen CE
Internet Interv; 2022 Apr; 28():100536. PubMed ID: 35433277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
